123O Randomized phase II trial of neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in early HER2-positive breast cancer (ABCSG-52/ATHENE)
| Autor: | Rinnerthaler, G., Egle, D., Bartsch, R., Schmitt, C.A., Petzer, A.L., Balic, M., Petru, E., Denison, U., Singer, C.F., Bjelic-Radisic, V., Gampenrieder, S.P., Knauer, M., Posch, F., Hlauschek, D., Sölkner, L., Bago-Horvath, Z.A., Filipits, M., Gili, M., Gnant, M.I., Greil, R. |
|---|---|
| Zdroj: | In ESMO Open May 2023 8(1) Supplement 4 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|